U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Recurrent ear infections

MedGen UID:
473277
Concept ID:
C0743360
Finding
Synonym: Ear infections, recurrent
 
HPO: HP:0410018

Definition

Increased susceptibility to ear infections, as manifested by recurrent episodes of ear infections. [from HPO]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVRecurrent ear infections

Conditions with this feature

Uruguay Faciocardiomusculoskeletal syndrome
MedGen UID:
335320
Concept ID:
C1846010
Disease or Syndrome
Uruguay faciocardiomusculoskeletal syndrome (FCMSU) is an X-linked disorder in which affected males have a distinctive facial appearance, muscular hypertrophy, and cardiac ventricular hypertrophy leading to premature death. Additional features include large, broad, and deformed hands and feet, congenital hip dislocation, and scoliosis (summary by Xue et al., 2016).
Intellectual disability, autosomal dominant 1
MedGen UID:
409857
Concept ID:
C1969562
Mental or Behavioral Dysfunction
MBD5 haploinsufficiency is a neurodevelopmental disorder characterized by developmental delay, intellectual disability, severe speech impairment, seizures, sleep disturbances, and abnormal behaviors. Most children lack speech entirely or have single words, short phrases, or short sentences. Seizures are present in more than 80% of children; onset is usually around age two years. Sleep disturbances, present in about 90%, can result in excessive daytime drowsiness. Abnormal behaviors can include autistic-like behaviors (80%) and self-injury and aggression (>60%).
Congenital disorder of glycosylation type Ir
MedGen UID:
482714
Concept ID:
C3281084
Disease or Syndrome
Congenital disorder of glycosylation type Ir (CDG1R) is an autosomal recessive disorder characterized by developmental delay, failure to thrive, feeding difficulties, hypotonia, and strabismus. Transferrin analysis demonstrates underglycosylation (summary by Pi et al., 2022). For a discussion of the classification of CDGs, see CDG1A (212065).
Obesity due to congenital leptin deficiency
MedGen UID:
767138
Concept ID:
C3554224
Disease or Syndrome
Leptin deficiency or dysfunction (LEPD) is characterized by severe early-onset obesity, hyperphagia, hypogonadotropic hypogonadism, and neuroendocrine/metabolic dysfunction (Ozata et al., 1999).
Immunodeficiency 14
MedGen UID:
811535
Concept ID:
C3714976
Disease or Syndrome
Activated PI3K-delta syndrome (also known as APDS) is a disorder that impairs the immune system. Individuals with this condition often have low numbers of white blood cells (lymphopenia), particularly B cells and T cells. Normally, these cells recognize and attack foreign invaders, such as viruses and bacteria, to prevent infection. The severity of activated PI3K-delta syndrome varies widely. Some people may have multiple, severe infections while others show mild symptoms to none at all.\n\nMost commonly, people with activated PI3K-delta syndrome develop recurrent infections that begin in childhood, particularly in the lungs, sinuses, and ears. Over time, recurrent respiratory tract infections can lead to a condition called bronchiectasis, which damages the passages leading from the windpipe to the lungs (bronchi) and can cause breathing problems. People with activated PI3K-delta syndrome may also have chronic active viral infections, such as Epstein-Barr virus, herpes simplex virus, or cytomegalovirus infections.\n\nAnother possible feature of activated PI3K-delta syndrome is abnormal clumping of white blood cells. These clumps can lead to enlarged lymph nodes (lymphadenopathy) or an enlarged spleen (splenomegaly). The white blood cells can also build up to form solid masses (nodular lymphoid hyperplasia), usually in the moist lining of the airways or intestines. While nodular lymphoid hyperplasia is not cancerous (benign), activated PI3K-delta syndrome increases the risk of developing forms of blood cancer called Hodgkin lymphoma and non-Hodgkin lymphoma.\n\nThere are two types of activated PI3K-delta syndrome, each with different genetic causes.\n\nSome people with activated PI3K-delta syndrome develop autoimmunity, which occurs when the body attacks its own tissues and organs by mistake.
Developmental delay, impaired speech, and behavioral abnormalities
MedGen UID:
1794167
Concept ID:
C5561957
Disease or Syndrome
Developmental delay, impaired speech, and behavioral abnormalities (DDISBA) is characterized by global developmental delay apparent from early childhood. Intellectual disability can range from mild to severe. Additional variable features may include dysmorphic facial features, seizures, hypotonia, motor abnormalities such as Tourette syndrome or dystonia, and hearing loss (summary by Cousin et al., 2021).
Neurodevelopmental disorder with gait disturbance, dysmorphic facies, and behavioral abnormalities, X-linked
MedGen UID:
1823953
Concept ID:
C5774179
Disease or Syndrome
Hijazi-Reis syndrome (HIJRS) is an X-linked dominant disorder characterized by global developmental delay with hypotonia, motor delay, impaired intellectual development, and speech and language delay. Affected individuals also have dysmorphic facial features, gastrointestinal issues, and ocular anomalies. Rare patients have seizures (Hijazi et al., 2022).

Professional guidelines

PubMed

Allen DZ, Rawlins K, Onwuka A, Elmaraghy CA
Int J Pediatr Otorhinolaryngol 2019 Aug;123:47-50. Epub 2019 Apr 25 doi: 10.1016/j.ijporl.2019.04.025. PMID: 31063948
Carter EM, Davis JG, Raggio CL
Curr Opin Pediatr 2007 Feb;19(1):32-7. doi: 10.1097/MOP.0b013e328013e3d9. PMID: 17224659

Recent clinical studies

Etiology

Molaug I, Engdahl B, Degerud E, Mehlum IS, Aarhus L
Occup Med (Lond) 2022 Dec 31;72(9):622-628. doi: 10.1093/occmed/kqac085. PMID: 36039845Free PMC Article
Xu J, Gilbert JR, Sutton KS, Goudy SL, Abramowicz S
J Oral Maxillofac Surg 2022 Mar;80(3):545-552. Epub 2021 Nov 5 doi: 10.1016/j.joms.2021.10.014. PMID: 34852246
Engdahl B, Stigum H, Aarhus L
BMC Public Health 2021 Jan 28;21(1):242. doi: 10.1186/s12889-021-10301-1. PMID: 33509127Free PMC Article
Eldeirawi K, McConnell R, Furner S, Freels S, Stayner L, Hernandez E, Amoruso L, Torres S, Persky V
J Asthma 2010 May;47(4):473-7. doi: 10.3109/02770901003759428. PMID: 20528604
Ochs HD
Semin Hematol 1998 Oct;35(4):332-45. PMID: 9801262

Diagnosis

Xu J, Gilbert JR, Sutton KS, Goudy SL, Abramowicz S
J Oral Maxillofac Surg 2022 Mar;80(3):545-552. Epub 2021 Nov 5 doi: 10.1016/j.joms.2021.10.014. PMID: 34852246
Allen DZ, Rawlins K, Onwuka A, Elmaraghy CA
Int J Pediatr Otorhinolaryngol 2019 Aug;123:47-50. Epub 2019 Apr 25 doi: 10.1016/j.ijporl.2019.04.025. PMID: 31063948
Eldeirawi K, McConnell R, Furner S, Freels S, Stayner L, Hernandez E, Amoruso L, Torres S, Persky V
J Asthma 2010 May;47(4):473-7. doi: 10.3109/02770901003759428. PMID: 20528604
Carter EM, Davis JG, Raggio CL
Curr Opin Pediatr 2007 Feb;19(1):32-7. doi: 10.1097/MOP.0b013e328013e3d9. PMID: 17224659
Ochs HD
Semin Hematol 1998 Oct;35(4):332-45. PMID: 9801262

Therapy

Molaug I, Engdahl B, Degerud E, Mehlum IS, Aarhus L
Occup Med (Lond) 2022 Dec 31;72(9):622-628. doi: 10.1093/occmed/kqac085. PMID: 36039845Free PMC Article
Engdahl B, Stigum H, Aarhus L
BMC Public Health 2021 Jan 28;21(1):242. doi: 10.1186/s12889-021-10301-1. PMID: 33509127Free PMC Article
Allen DZ, Rawlins K, Onwuka A, Elmaraghy CA
Int J Pediatr Otorhinolaryngol 2019 Aug;123:47-50. Epub 2019 Apr 25 doi: 10.1016/j.ijporl.2019.04.025. PMID: 31063948
Hawkins SS, Berkman L
J Adolesc Health 2011 Jun;48(6):647-50. Epub 2010 Dec 13 doi: 10.1016/j.jadohealth.2010.09.017. PMID: 21575830
Eldeirawi K, McConnell R, Furner S, Freels S, Stayner L, Hernandez E, Amoruso L, Torres S, Persky V
J Asthma 2010 May;47(4):473-7. doi: 10.3109/02770901003759428. PMID: 20528604

Prognosis

Engdahl B, Aarhus L
BMC Public Health 2024 Feb 15;24(1):474. doi: 10.1186/s12889-024-17852-z. PMID: 38355451Free PMC Article
Baruah P, Hanvey K, Irving R, Tzifa K
Otol Neurotol 2017 Jun;38(5):672-677. doi: 10.1097/MAO.0000000000001372. PMID: 28333779
Amin SB, Prinzing D, Myers G
Pediatrics 2009 Jan;123(1):327-31. doi: 10.1542/peds.2007-3723. PMID: 19117899Free PMC Article
Tambs K, Hoffman HJ, Borchgrevink HM, Holmen J, Samuelsen SO
Int J Audiol 2003 Mar;42(2):89-105. doi: 10.3109/14992020309078340. PMID: 12641392
Lieu JE, Feinstein AR
Arch Pediatr Adolesc Med 2002 Feb;156(2):147-54. doi: 10.1001/archpedi.156.2.147. PMID: 11814376

Clinical prediction guides

Bemanian MH, Arshi S, Nabavi M, Vafaee-Shahi M, Fallahpour M, Shokri S, Rezaeifar A, Shahzadi H, Atashrazm F
Iran J Allergy Asthma Immunol 2021 Apr 17;20(2):249-254. PMID: 33904683
Kaur H, Thom RP, Neumeyer AM, Bilancia CG, Wray SH, McDougle CJ
Psychiatr Genet 2020 Aug;30(4):119-123. doi: 10.1097/YPG.0000000000000256. PMID: 32459710
Simas V, Remnant D, Furness J, Bacon CJ, Moran RW, Hing WA, Climstein M
J Prim Health Care 2019 Apr;11(1):47-53. doi: 10.1071/HC18097. PMID: 31039989
Baruah P, Hanvey K, Irving R, Tzifa K
Otol Neurotol 2017 Jun;38(5):672-677. doi: 10.1097/MAO.0000000000001372. PMID: 28333779
Tambs K, Hoffman HJ, Borchgrevink HM, Holmen J, Samuelsen SO
Int J Audiol 2003 Mar;42(2):89-105. doi: 10.3109/14992020309078340. PMID: 12641392

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...